Transcriptomics

Dataset Information

0

ATAXIN-2 Intermediate-length Polyglutamine Expansions Elicit ALS-associated Metabolic and Immune Phenotypes

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE224585 | GEO | 2024/07/16

REPOSITORIES: GEO

Json Xml

Similar Datasets

Unknown Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.
| S-EPMC2965417 | biostudies-literature
Unknown C9orf72 intermediate expansions of 24-30 repeats are associated with ALS.
| S-EPMC6637621 | biostudies-literature
Unknown Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
| S-EPMC2630800 | biostudies-literature
Unknown PolyQ-expanded ataxin-3 interacts with full-length ataxin-3 in a polyQ length-dependent manner.
| S-EPMC5552588 | biostudies-other
Unknown Polyglutamine Tract Expansion Increases S-Nitrosylation of Huntingtin and Ataxin-1.
| S-EPMC5033456 | biostudies-literature
Unknown The impact of ataxin-1-like histidine insertions on polyglutamine aggregation.
| S-EPMC2719497 | biostudies-literature
Transcriptomics Transcriptomic analysis of iPSC-derived motor neurons from ALS patients carrying ATXN2 intermediate repeat expansions and healthy controls
2024-07-16 | GSE224578 | GEO
Unknown Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.
| S-EPMC4617164 | biostudies-literature
Unknown Effects of the enlargement of polyglutamine segments on the structure and folding of ataxin-2 and ataxin-3 proteins.
| S-EPMC5580338 | biostudies-literature
Unknown Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis.
| S-EPMC3111240 | biostudies-literature